Sonographic Imaging in Infertility and Assisted Reproduction


Summary of Key Points

  • Transvaginal sonography (TVS) provides valuable information as part of the initial evaluation of an infertile patient.

  • EVS has an essential role in monitoring endometrial thickness and morphology as well as follicular development during hormonal stimulation.

  • EVS or transabdominal sonography provides guidance for oocyte retrieval.

  • Postretrieval complications such as ovarian hyperstimulation, hemorrhage, and infection are optimally imaged with sonography.

Infertility can be defined as the inability to conceive a pregnancy after 1 year of unprotected intercourse or after 6 months in a woman over 35 years old. It affects between 6% and 10% of couples in the United States. Because fertility peaks in the third decade and subsequently declines, the age of the female partner is an important variable in the treatment of infertility. The use of sonography, in particular EVS, has become an integral component of the evaluation and treatment of infertility. The transvaginal approach allows high-resolution assessment of the uterus, ovaries, and fallopian tubes. EVS plays a critical role in the diagnosis and treatment of infertile women in combination with serologic testing, physical examination, and careful assessment of medical and surgical history, as well as evaluation of the male partner. Initial baseline ultrasound examination is used primarily to identify structural abnormalities that might affect fertility such as uterine anomalies, endometrial polyps or submucosal leiomyomas, endometrial adhesions/synechiae, or hydrosalpinges. Sonography is also used to assess for possible underlying pathologic processes associated with infertility such as adenomyosis, endometriosis, polycystic ovary syndrome (PCOS), and low antral follicular count. If the baseline pelvic sonogram is inconclusive or noncontributory, further anatomic evaluation can be obtained by means of pelvic magnetic resonance imaging (MRI), hysterography, sonohysterography, or even hysteroscopy and laparoscopy, as indicated. It is estimated that ovulatory defects are the primary cause of infertility in 20% to 40% of infertile women. Structural abnormalities of the female reproductive tract account for approximately 30% of cases; male factors up to 35%; and cervical mucosal, peritoneal, or unexplained abnormalities account for approximately 10% to 15%. Once a treatment plan has been established, sonography plays an important role in monitoring response, particularly in assessing folliculogenesis and endometrial receptivity. In addition, ultrasound imaging is crucial for guiding infertility treatment such as oocyte retrieval and in assessing posttreatment complications. This chapter will review the role of sonographic imaging in the diagnosis and treatment of women presenting with infertility.

Initial Evaluation

Part of the initial evaluation of all women with infertility is an assessment of pelvic anatomy. Although high-resolution EVS is the preferred method for imaging the pelvic organs, an initial overview using a transabdominal approach should be performed to evaluate for the possible presence of an enlarged uterus or other pelvic mass. Transvaginal probes are higher frequency than transabdominal transducers and, thus, provide high-resolution images of the uterus, ovaries, and fallopian tubes, but with the tradeoff of reduced penetration and smaller field of view. Masses that extend out of the pelvis cannot be fully imaged or characterized with the transvaginal approach, as they extend beyond the field of view of the transducer. A formal transabdominal sonogram, performed with a distended urinary bladder, or a combination of both transabdominal and transvaginal imaging may be required in some patients. A baseline transvaginal sonographic examination consists of images of the uterus, endometrium, and ovaries, with additional targeted evaluation of any identified abnormality. The reader is referred to individual chapters elsewhere in this textbook about the uterus ( Chapter 28 ), ovaries ( Chapter 30 ), and fallopian tubes ( Chapter 31 ) for additional detail.

Baseline Evaluation

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here